Study findings show that the standardized 6-month surveillance protocols for all patients with low-risk uveal melanoma may be ...

In January 2025, Melanoma Institute Australia announced a phase II, open label, randomised trial of ipilimumab and nivolumab ...

A new study finds that fragments of tumor DNA in a patient's bloodstream could show that they are at high risk of a melanoma ...

The “Real Housewives of Beverly Hills” star recently revealed that her dad has planned her funeral as her melanoma has spread ...

Neoadjuvant pepinemab treatment shows potential to enhance immune response and improve survival in metastatic melanoma and head and neck cancer. Vaccinex, Inc. announced promising findings ...

Recurrence-free survival rates were similar, even when patients quit adjuvant immunotherapy early, according to a new report.

Sep. 16, 2024 — Long-term data from a landmark international trial show about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer ...

A new way to deliver cancer medicine directly to the liver may help patients with a rare and aggressive type of eye cancer ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.